The ability to manipulate images with digital mammography can result in fewer callbacks, and breast imaging centers could reduce costs associated with scheduling new appointments, reregistering patients, and rereviewing mammography exams.
The ability to manipulate images with digital mammography can result in fewer callbacks, and breast imaging centers could reduce costs associated with scheduling new appointments, reregistering patients, and rereviewing mammography exams.
Callbacks can result from technical reasons, such as poor patient positioning or patient movement, and from possible or definite abnormalities seen on the exam.
The use of digital mammography at Brigham and Women's Hospital resulted in significantly fewer callbacks of both types, according to a study presented Tuesday at the American Roentgen Ray Society meeting.
For patients, fewer callbacks reduce absenteeism, potential child care costs, and the anxiety associated with being asked to return, said coauthor Dr. Elisabeth Pepperell Frost, a staff radiologist at BWH.
The hospital switched from screen-film to digital mammography in 2003. Investigators led by Dr. Sughra Raza retrospectively reviewed callback rates from pre- and post-digital era.
During one six-month period, the callback rate for 6189 conventional screen-film mammograms was 4.4%. The callback rate for 6792 digital exams during a similar six-month stretch was 3.2%. The difference was significant, Frost said.
Technical improvements in the quality of the exam and the ability to manipulate digital views contributed to fewer callbacks. Specifically, digitally magnifying images reduced the need bring patients back for magnification views.
Most callbacks for digital exams resulted from actual abnormalities seen on the exam, rather than from technical reasons.
For more information from the online Diagnostic Imaging archives:
Digital mammography wins over lingering skeptics
Debate intensifies over clinical superiority of digital systems
Digital mammography delivers rapid results
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.